ICG001: Applied Wnt/β-Catenin Pathway Inhibition in Fibrosis
2026-05-05
ICG001, a selective Wnt/β-catenin pathway inhibitor, empowers researchers to dissect CBP/β-catenin-mediated transcription in fibrosis and cancer models. This article spotlights actionable workflows, experimental nuances, and troubleshooting insights anchored in the latest mechanistic studies of EMT-driven liver fibrosis.
Dextrose (D-glucose): Optimizing Glucose Metabolism Research
2026-05-04
Dextrose (D-glucose) empowers reproducible metabolic assays, especially in hypoxic tumor and immune microenvironments. This article reveals practical setup tips, advanced use-cases, and troubleshooting strategies to maximize data reliability in glucose metabolism research.
ICG001 and the CBP/β-Catenin Axis: Translational Leverage in
2026-05-04
Translational researchers face a growing imperative to pinpoint and modulate the molecular drivers of fibrosis and cancer. Recent studies underscore the pivotal role of the Wnt/β-catenin pathway, particularly the CBP/β-catenin interaction, in orchestrating disease progression through mechanisms like EMT. This article synthesizes mechanistic insight—anchored by the latest data on MMP7-driven fibrotic signaling—while offering strategic guidance on leveraging ICG001 for robust, reproducible, and actionable translational models.
LMO2-LDB1 Complex Drives AML Progression: Mechanistic Insigh
2026-05-03
This study delineates how the LMO2 transcription factor interacts with LDB1 to promote acute myeloid leukemia (AML) cell proliferation and survival, identifying the LMO2/LDB1 complex as a potential therapeutic target. Integrating RNA-seq, ChIP-seq, and functional assays, the research highlights the essential oncogenic roles of both proteins in AML and provides a foundation for future epigenetic and genomic stability studies.
Cy5 NHS ester(Et): Technical Guide for Protein Fluorescent L
2026-05-02
Cy5 NHS ester(Et) solves the challenge of covalently labeling amino groups in proteins and other biomolecules with a water-soluble, amine-reactive fluorescent dye for immediate use in detection workflows. It is not suitable for workflows requiring ethanol solubility or long-term storage of dye solutions.
PR-619: Technical Reference for Deubiquitylating Enzyme Inhi
2026-05-02
PR-619 is a reversible, broad-spectrum deubiquitylating enzymes inhibitor designed for cell-based studies where selective DUB inhibition is required without directly blocking proteasomal activity. Its workflow is suited for ubiquitination pathway research, autophagy activation assays, and disease modeling in cancer and neurodegeneration, but it is not compatible with water- or ethanol-based protocols or long-term solution storage.
WNT Switch Method Enhances mESC Cardiomyocyte Differentiatio
2026-05-01
Mensah et al. (2024) introduce the 'WNT Switch' protocol to efficiently produce cardiomyocytes from mouse embryonic stem cells by temporally modulating Wnt/β-catenin signaling with small molecules including CHIR-99021. This approach increases yield and reproducibility, streamlining in vitro cardiac modeling and supporting disease research and regenerative workflows.
Moesin as a Biomarker of Endothelial Injury in Sepsis: Evide
2026-04-30
This article reviews recent evidence identifying moesin (MSN) as a novel biomarker of endothelial injury in sepsis, highlighting its mechanistic role in vascular dysfunction and inflammation. The findings position MSN as a promising indicator for sepsis severity and therapeutic targeting, with implications for translational research into endothelial protection.
High-Throughput Profiling Reveals Novel Mtb DHFR Inhibitors
2026-04-30
Santa Maria et al. present an integrated approach combining high-throughput biophysical screening and machine learning to elucidate mechanisms of action and discover potent inhibitors of Mycobacterium tuberculosis dihydrofolate reductase (DHFR). This framework enhances target identification and advances antibacterial agent discovery, informing tuberculosis research and drug development.
H 89 2HCl in Neuronal Signaling: Optimizing PKA Inhibition W
2026-04-29
H 89 2HCl empowers researchers to dissect cAMP/PKA signaling and unravel kinase-regulated neuronal behaviors with precision. This article details advanced experimental workflows, troubleshooting solutions, and translational strategies centered on PKA inhibition, highlighting unique insights from recent autism research.
Saquinavir: Optimizing HIV Protease Inhibitor Workflows
2026-04-29
Saquinavir from APExBIO accelerates robust antiretroviral and cancer research by enabling precision workflows and advanced permeability modeling. This guide translates recent biomimetic chromatography breakthroughs and benchmark protocols into actionable strategies for data-driven HIV infection and pharmacokinetic studies.
Oxaliplatin in Chemoresistance Research: Mechanisms and Mode
2026-04-28
Explore how Oxaliplatin, a platinum-based chemotherapeutic agent, advances cancer chemotherapy research and resistance modeling. This in-depth analysis reveals new scientific insights and practical guidance for oncology assay design.
Entecavir (BMS200475): Resistance Risk, Clinical Precision,
2026-04-28
Explore how Entecavir (BMS200475) redefines chronic hepatitis B virus replication inhibition through a data-driven focus on resistance risk and assay optimization. This article uniquely bridges meta-analytic insights with practical recommendations for clinical and research protocols.
Drug-Sensitized Yeast Platform Reveals Selective mTOR Inhibi
2026-04-27
This study presents a highly sensitive yeast-based screening system for identifying mTOR/TOR inhibitors, dramatically increasing detection sensitivity over wild-type models. The findings clarify the specificity of candidate compounds, including the confirmation that Nebivolol hydrochloride does not inhibit TOR, thus supporting more accurate pathway-targeted drug discovery.
Lipid Peroxidation (MDA) Assay Kit: Precision in Oxidative S
2026-04-27
The Lipid Peroxidation (MDA) Assay Kit empowers researchers to achieve sensitive, reproducible quantification of malondialdehyde, a pivotal oxidative stress biomarker, across diverse biological matrices. Its dual-mode colorimetric and fluorescence readouts, robust antioxidant protection, and seamless workflow optimization set it apart for translational and mechanistic studies in ferroptosis and liver injury.
462 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page